Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Cogstate Ltd (CGS AU)
Watchlist
12
Analysis
Health Care
•
Australia
CogState Limited manufactures and distributes diagnostic and therapeutic products associated with neurological disorders and the measurement of cognitive functions.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Cogstate Ltd
•
06 May 2023 07:22
•
Broker
Cogstate - Donanemab Strikes Second ‘home Run’ for AD Drug Development
Eli Lilly has reported positive results from its Donanemab confirmatory phase 3 study, meeting both primary and secondary endpoints.
CCZ Statton Equities
Follow
346 Views
Share
bullish
•
Cogstate Ltd
•
21 Apr 2023 22:43
•
Broker
Cogstate - Eyes on the Prize Despite a Temporary Sales Slowdown
CGS provided a Q3’FY23 trading update with group revenue of $10.9m, +18% vs pcp or $30.5m YTD. New clinical trial (CT) contract sales have been...
CCZ Statton Equities
Follow
370 Views
Share
bullish
•
Cogstate Ltd
•
04 Mar 2023 08:13
•
Broker
Cogstate - Remembering What Matters
CGS’s result was largely pre-announced with rev of $19.5m and EBIT -$0.2m. Clinical trial segment rev was $17.1m, -18% vs pcp impacted by c.$3.3m...
CCZ Statton Equities
Follow
285 Views
Share
bullish
•
Cogstate Ltd
•
04 Mar 2023 07:46
•
Broker
Cogstate - Down but Not Out
Delayed clinical trials affected 1H'FY23 revenue, resulting in a -12% decrease to $17.1m, with c.$5m of revenue moved to FY24+.
CCZ Statton Equities
Follow
277 Views
Share
bullish
•
Cogstate Ltd
•
12 Nov 2022 06:59
•
Broker
Cogstate - Is History About to Repeat Itself?
A commercially successful drug would warrant new funding to expand its applications. Most of the lifetime investment into a drug occurs after first...
CCZ Statton Equities
Follow
311 Views
Share
1
2
3
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x